Site search
2816 results for '' found
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Imatinib Combined with Chemotherapy in Patients with Newly Diagnosed
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Imatinib Combined with Chemotherapy in Patients with Newly Diagnosed
/research/clinical-trials/find-clinical-trials/a-global-multicenter-open-label-randomized-phase-3-registrational-study-of-olverembatinib-combined-with-chemotherapy-versus-imatinib-combined-with-chemotherapy-in-patients-with-newly-diagnosed
A Single-Arm Registrational Phase III Study of Olverembatinib in the Treatment of Patients with SDH-Deficient Gastrointestinal Stromal Tumor [POLARIS-3] (NCT06640361)
A Single-Arm Registrational Phase III Study of Olverembatinib in the Treatment of Patients with SDH-Deficient Gastrointestinal Stromal Tumor [POLARIS-3] (NCT06640361)
/research/clinical-trials/find-clinical-trials/a-single-arm-registrational-phase-iii-study-of-olverembatinib-in-the-treatment-of-patients-with-sdh-deficient-gastrointestinal-stromal-tumor-polaris-3-nct06640361
Development of Clinical Utility for Point of Care MRI (Trial Not Registered)
Development of Clinical Utility for Point of Care MRI (Trial Not Registered)
/research/clinical-trials/find-clinical-trials/development-of-clinical-utility-for-point-of-care-mri-trial-not-registered
PMR-116 in Patients with Advanced Malignancies (ACTRN12620001146987)
PMR-116 in Patients with Advanced Malignancies (ACTRN12620001146987)
/research/clinical-trials/find-clinical-trials/pmr-116-in-patients-with-advanced-malignancies-actrn12620001146987
A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis
A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis
/research/clinical-trials/find-clinical-trials/a-phase-3-randomized-double-blind-add-on-study-evaluating-the-safety-and-efficacy-of-navtemadlin-plus-ruxolitinib-vs-placebo-plus-ruxolitinib-in-jak-inhibitor-naive-patients-with-myelofibrosis
A Proof Of Concept study to evaluate the sensitivity and specificity of Wearables and Algorithm Technology for Chronic Heart Disease for improved diagnosis of Heart Failure (ACTRN12623000038695)
A Proof Of Concept study to evaluate the sensitivity and specificity of Wearables and Algorithm Technology for Chronic Heart Disease for improved diagnosis of Heart Failure (ACTRN12623000038695)
/research/clinical-trials/find-clinical-trials/a-proof-of-concept-study-to-evaluate-the-sensitivity-and-specificity-of-wearables-and-algorithm-technology-for-chronic-heart-disease-for-improved-diagnosis-of-heart-failure-actrn12623000038695
A prospective, randomized, single-blinded, sham controlled study of Pelvic Vein Embolization (PVE) for treatment of erectile dysfunction (ED) (ACTRN12620001023943)
A prospective, randomized, single-blinded, sham controlled study of Pelvic Vein Embolization (PVE) for treatment of erectile dysfunction (ED) (ACTRN12620001023943)
/research/clinical-trials/find-clinical-trials/a-prospective-randomized-single-blinded-sham-controlled-study-of-pelvic-vein-embolization-pve-for-treatment-of-erectile-dysfunction-ed-actrn12620001023943
A Prospective angiOtensin vs. noRadrenaline Trial for Hypotension management to reduce length Of hospital stay in Cardiac Surgery (the PORTHOS study) (ACTRN12623000848606p)
A Prospective angiOtensin vs. noRadrenaline Trial for Hypotension management to reduce length Of hospital stay in Cardiac Surgery (the PORTHOS study) (ACTRN12623000848606p)
/research/clinical-trials/find-clinical-trials/a-prospective-angiotensin-vs-noradrenaline-trial-for-hypotension-management-to-reduce-length-of-hospital-stay-in-cardiac-surgery-the-porthos-study-actrn12623000848606p
A phase 2 randomised, open-label trial of maintenance of weight loss with alternate-weekly incretin medication dosing (ACTRN12625000609459)
A phase 2 randomised, open-label trial of maintenance of weight loss with alternate-weekly incretin medication dosing (ACTRN12625000609459)
/research/clinical-trials/find-clinical-trials/a-phase-2-randomised-open-label-trial-of-maintenance-of-weight-loss-with-alternate-weekly-incretin-medication-dosing-actrn12625000609459
PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial (NCT03737409)
PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial (NCT03737409)
/research/clinical-trials/find-clinical-trials/pfox-pulmonary-fibrosis-ambulatory-oxygen-trial-nct03737409